CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $1.0M of Cerevel Therapeutics Holdings, Inc.
Sold$1,029,535
$41.18Price
25,000Shares
−49%Stake
What CERE did after the filing
- The stock from Wed, Jul 3 close, $40.30
- +11.6%
- S&P 500, same days
- −0.1%
19 of 30 trading days so far, to the Jul 31 close.
Traded Mon, Jul 1. Filed Wed, Jul 3, 12:05 PM ET, during the session. Returns use the Jul 3 close and the Jul 31 close. Not investment advice.